Benitec Biopharma Inc.
(NASDAQ:BNTC)
$3.05
-0.13 (-4.09%)
At Close: 4:00 PM
BNTC Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BNTC Stock Price Today
Benitec Biopharma Inc. (BNTC) stock declined over -4.09% intraday to trade at $3.05 a share on NASDAQ. The stock opened with a gain of 5.66% at $3.36 and touched an intraday high of $3.50, falling -4.09% against the last close of $3.18. The Benitec Biopharma Inc. in stock market went to a low of $3.36 during the session.
BNTC Stock Snapshot
$3.18
Prev. Close
7.78 Million
Market Cap
$3.36
Day Low
$3.36
Open
N/A
Number of Shares
$3.50
Day High
N/A
P/E ratio
-11.60
EPS (TTM)
10.05
Cash Flow per Share
N/A
Free Float in %
8.76
Book Value
10847.00
Volume
BNTC Stock Price History Chart
Date | Open | High | Low | Close | Volume |
---|
Contact Details
Company Information
EmployeesN/A
Beta0.92
Sales or Revenue$75 Thousands
5Y Sales Change748.79%
Fiscal Year EndsJun. 2023
SectorHealthcare
IndustryBiotechnology
About Company
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Peers
Frequently Asked Questions
What is the current Benitec Biopharma Inc. (BNTC) stock price?
Benitec Biopharma Inc. (NASDAQ: BNTC) stock price is $3.05 in the last trading session. During the trading session, BNTC stock reached the peak price of $3.50 while $3.36 was the lowest point it dropped to. The percentage change in BNTC stock occurred in the recent session was -4.09% while the dollar amount for the price change in BNTC stock was -$0.13.
BNTC's industry and sector of operation?
The NASDAQ listed BNTC is part of Biotechnology industry that operates in the broader Healthcare sector. Benitec Biopharma Inc. , a development-stage biotechnology company, focuses on the development of novel genetic medicines.
Who are the executives of BNTC?
Dr. Jerel A. Banks M.D., Ph.D.
Executive Chairman & Chief Executive Officer
Dr. Craig Lewis
Chief Medical Adviser
Mr. Bryan Dulhunty
Chief Financial Officer
Dr. Jerel A. Banks M.D., Ph.D.
Exec. Chairman & CEO
How BNTC did perform over past 52-week?
BNTC's closing price is 0.72% higher than its 52-week low of $1.86 where as its distance from 52-week high of $9.01 is -0.89%.
How many employees does BNTC have?
Number of BNTC employees currently stands at N/A. BNTC operates from 3940 Trust Way, Hayward, CA 94545, US.
Link for BNTC official website?
Official Website of BNTC is: https://benitec.com
How do I contact BNTC?
BNTC could be contacted at phone #510 780 0819 and can also be accessed through its website. BNTC operates from 3940 Trust Way, Hayward, CA 94545, US.
How many shares of BNTC are traded daily?
BNTC stock volume for the day was 10847.00 shares. The average number of BNTC shares traded daily for last 3 months was 19.86 Thousands.
What is the market cap of BNTC currently?
The market value of BNTC currently stands at $7.78 Million with its latest stock price at $3.05 and N/A of its shares outstanding.